Cobalt Carboxylate Toxicity
Identifiers
Hazards
What are the material safety considerations for cobalt carboxylate?
Cobalt carboxylate presents serious health and environmental hazards requiring strict handling controls. It is classified as a skin and respiratory sensitizer (H317, H334), suspected germ cell mutagen (H341), carcinogenic by inhalation (H350i), and toxic to reproduction (H360F). It also causes organ damage from single or repeated exposure (H371, H372) and is very toxic to aquatic life with long-lasting effects (H410). Acute oral toxicity is moderate (rat LD50 503 mg/kg), but intravenous toxicity is high (rabbit LD50 25 mg/kg). These classifications mandate comprehensive safety protocols for any formulation or industrial use.
How should hazard classifications and toxicology findings for cobalt carboxylate be interpreted together?
The GHS classifications and toxicology data together indicate that cobalt carboxylate poses systemic and chronic health risks, not just acute irritation. The inhalation unit risk of 0.00086 (µg/m³)⁻¹ from CALEPA supports the carcinogenicity classification, while the ACGIH TLV of 0.02 mg/m³ (as Co) and A3 designation (confirmed animal carcinogen) reinforce the need for stringent exposure control. The reproductive toxicity and germ cell mutagenicity classifications suggest potential heritable effects, making this a high-concern substance for product development. These findings should be integrated into risk assessments, not treated as isolated warnings.
Which exposure routes, dose contexts, or effects are material for cobalt carboxylate?
Material exposure routes for cobalt carboxylate are inhalation, oral, and dermal. Inhalation is the most critical route due to respiratory sensitization (H334), respiratory irritation (H335), and carcinogenicity by inhalation (H350i). Oral exposure is harmful (H302) with a rat LD50 of 503 mg/kg, and dermal contact causes allergic skin reactions (H317). The ACGIH biological exposure index for cobalt in urine (15 µg/L at end of shift) provides a monitoring benchmark for occupational exposure. These routes and effects should guide exposure assessment and product safety communication.
Which handling and risk-management measures are relevant for cobalt carboxylate?
Handling measures must prioritize preventing inhalation and skin contact. First aid includes moving to fresh air after inhalation, inducing vomiting after ingestion, flushing eyes for 15 minutes, and washing skin with soap and water. Storage should be in tightly closed containers in a dry, well-ventilated area, separated from strong oxidants. The ACGIH TLV of 0.02 mg/m³ (as Co) and peak exposure recommendations (not exceeding 3x TLV for 15 minutes) should be implemented as occupational exposure limits. These controls are essential for regulatory compliance and worker safety.
Which safety evidence gaps should be resolved before making decisions about cobalt carboxylate?
Before finalizing safety decisions, resolve the lack of cobalt carboxylate-specific exposure limits and toxicological data. The available TLV and BEI are for cobalt and inorganic compounds, not this carboxylate, which may have different bioavailability and toxicity. Additionally, the inhalation unit risk is from CALEPA, and other regulatory assessments may differ. Clarify the carcinogenicity classification (H350i vs. H350) and reproductive toxicity specifics (H360F) for this exact substance. These gaps are critical for accurate risk assessment and regulatory compliance.